Anhui Huangshan Capsule Co Ltd
Anhui Huangshan Capsule Co., Ltd. engages in the research and development, production, and sale of gelatin and enteric-coated gelatin empty capsules in China. It offers hypromellose empty capsules, pullulan empty capsules, entersoluble vacant gelatin capsules, vacant gelatin capsules, vegetable entersoluble capsules, colonsoluble vacant gelatin capsules, hydroxypropyl methyl cellulose hollow caps… Read more
Anhui Huangshan Capsule Co Ltd - Asset Resilience Ratio
Anhui Huangshan Capsule Co Ltd (002817) has an Asset Resilience Ratio of 4.78% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2022)
This chart shows how Anhui Huangshan Capsule Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Anhui Huangshan Capsule Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥49.58 Million | 4.78% |
| Total Liquid Assets | CN¥49.58 Million | 4.78% |
Asset Resilience Insights
- Limited Liquidity: Anhui Huangshan Capsule Co Ltd maintains only 4.78% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Anhui Huangshan Capsule Co Ltd Industry Peers by Asset Resilience Ratio
Compare Anhui Huangshan Capsule Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Anhui Huangshan Capsule Co Ltd (2016–2022)
The table below shows the annual Asset Resilience Ratio data for Anhui Huangshan Capsule Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 4.78% | CN¥49.58 Million | CN¥1.04 Billion | -1.40pp |
| 2021-12-31 | 6.18% | CN¥65.14 Million | CN¥1.05 Billion | -4.71pp |
| 2020-12-31 | 10.89% | CN¥99.77 Million | CN¥915.81 Million | +1.09pp |
| 2019-12-31 | 9.80% | CN¥81.54 Million | CN¥831.80 Million | -2.38pp |
| 2017-12-31 | 12.18% | CN¥90.00 Million | CN¥738.73 Million | -10.70pp |
| 2016-12-31 | 22.88% | CN¥160.00 Million | CN¥699.36 Million | -- |